Roflumilast 00904-7493-71

Package NDC

00904-7493-71

Manufacturer: Major Pharmaceuticals
Dosage Form: Tablet
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: October 27, 2025
Listing Expires: December 31, 2026
Application: ANDA208256

Need to source Roflumilast? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Roflumilast	250 ug/1

Drug Class

Phosphodiesterase 4 Inhibitor [EPC]Phosphodiesterase 4 Inhibitor [EPC]Phosphodiesterase 4 Inhibitors [MoA]

Selected Package

00904-7493-71Selected

28 TABLET in 1 BOTTLE (0904-7493-71)